CA
REPL icon

Clearstead Advisors’s Replimune Group REPL Stock Holding History

Clearstead Advisors’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.83K Hold
500
– – ﹤0.01% 1777
2025
Q4 		$4.86K Buy
+500
New +$4.25K ﹤0.01% 2024

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Clearstead Advisors's REPL Position: Q1 2026 in Review

Clearstead Advisors held its Replimune Group (REPL) position steady in Q1 2026 at 500 shares worth $3.83K. The position accounts for ﹤0.01% of the portfolio, ranked #1777.

Clearstead Advisors first reported a position in REPL in Q4 2025 and has held it in 2 quarters since. The position peaked at $4.86K in Q4 2025. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • Clearstead Advisors held 500 shares of Replimune Group worth $3.83K as of Q1 2026.
  • Clearstead Advisors left its Replimune Group share count unchanged in Q1 2026.
  • Replimune Group made up ﹤0.01% of Clearstead Advisors's portfolio in Q1 2026, its #1777 holding.
  • Clearstead Advisors first reported a position in Replimune Group in Q4 2025 and has held it in 2 quarters since.
  • Clearstead Advisors's Replimune Group position peaked at $4.86K in Q4 2025.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Clearstead Advisors's 13F filing for Q1 2026, filed 6 May 2026.